Skip to main content
Erschienen in: Pediatric Rheumatology 1/2020

Open Access 01.12.2020 | Research article

Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease

verfasst von: Teresa Giani, Azzurra Bernardini, Massimo Basile, Marco Di Maurizo, Anna Perrone, Sara Renzo, Viola Filistrucchi, Rolando Cimaz, Paolo Lionetti

Erschienen in: Pediatric Rheumatology | Ausgabe 1/2020

Abstract

Background

Arthritis is often an underestimated extraintestinal manifestation in pediatric inflammatory bowel disease (IBD), including sacroiliitis, whose early signs are well detectable at magnetic resonance imaging (MRI). Magnetic resonance enterography (MRE) is an accurate imaging modality for pediatric IBD assessment.
We studied the possibility to detect signs of sacroiliac inflammation in a group of children with IBD who underwent MRE for gastrointestinal disease evaluation.

Methods

We retrospectively reviewed MRE scans performed in pediatric patients with IBD. We looked for signs of sacroiliitis taking the ASAS (Assessment of SpondyloArthritis international Society) criteria as a model. Presence of bone marrow edema (using T2W sequences with fat suppression), diffusion restriction in Diffusion Weighted Imaging (DWI) or Diffusion Weighted Imaging with Background Suppression (DWIBS), and dynamic contrast enhancement were evaluated. Each SI joint was divided into 4 quadrants: upper iliac, lower iliac, upper sacral, and lower sacral. Two blinded observers with experience in pediatric and skeletal imaging independently evaluated the images. Cases upon which there was a disagreement were evaluated by the two reviewing radiologists and a third radiologist with similar experience together.

Results

We enrolled 34 patients (24 males and 10 females, with mean age at scanning 14.3 years, median 15.3 years; 2 affected by ulcerative colitis, 32 by Crohn’s disease) for a total of 59 examinations performed at the time of their first diagnosis or at symptom exacerbations. No patient complained of musculoskeletal symptoms, neither had pathological findings at articular examination. At the time of MRE 25 patients were under treatment for their IBD. Five patients had radiological signs of SI inflammation at MRE, albeit of mild degree. All patients with SI joint edema also had a restricted diffusion in DWIBS or DWI and almost everyone had contrast media uptake.

Conclusions

Sacroiliitis is one of the extraintestinal manifestation associated with IBD; it is often asymptomatic and clinically underdetected, with an unrelated progression with respect to the underlying IBD. MRE offers the possibility to study SI joints in young patients with IBD who undergo MRE for the investigation of their intestinal condition. Furthermore, we observed that gadolinium enhancement does not improve diagnostic specificity in sacroiliiitis detection.
Hinweise
Teresa Giani and Azzurra Bernardini contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
SI
Sacroiliac
IBD
Inflammatory bowel disease
MRE
Magnetic resonance enterography
ASAS
Assessment of SpondyloArthritis international Society
DWI
Diffusion Weighted Imaging
DWIBS
Diffusion Weighted Imaging with Background Suppression
GI
Gastrointestinal
MRI
Magnetic Resonance Imaging
CD
Crohn’s disease
UC
Ulcerative Colitis

Background

Inflammatory bowel diseases (IBD), as Crohn’s disease (CD), and Ulcerative Colitis (UC), are a group of chronic and relapsing inflammatory conditions often diagnosed in patients younger than 20 years of age [1]. In addition to bowel symptoms, patients with IBD often present extraintestinal complications, such as arthritis, eye disorders, skin problems, kidney and liver disease [24].
The most common extraintestinal complication of these disorders is arthritis, which has been reported in 7 to 21% of children with IBD [5]. The causes of IBD and the concomitant arthritis remain unclear, although immunopathological overlap between gut inflammation and spondyloarthropathies has been demonstrated. Intestinal inflammation is believed to be heavily involved in the pathogenesis of spondyloarthropathy [6]. Two patterns of joint inflammation are described: peripheral polyarthritis and, less commonly, involvement of the sacroiliac (SI) joints and axial skeleton. Whereas the peripheral arthritis reflects the activity and course of the gastrointestinal (GI) inflammation, sacroiliitis may show poor correlation to the activity of gut disease [7], and may also be asymptomatic [5, 810]. In addition, no laboratory test is considered reliable for diagnosis and management of these conditions [11].
Althought infrequent, the SI involvement in the course of pediatric IBD is often asymptomatic and clinically underdetected; in addition, the inflammatory damage at SI joint may progress regardless of the control of the underlying IBD. Magnetic resonance imaging (MRI) is very sensitive in assessing subclinical sacroiliitis by identifying bone marrow edema as the primary sign of SI inflammation [12, 13], before any X-Ray sign is identifiable [1416].
On the other hand, MR enterography (MRE) is the current gold standard for imaging to assess IBD intestinal disease activity [17].
We studied the ability of MRE performed in a group of children affected by IBD for bowel evaluation in order to identify signs of SI inflammation.
In recent years only few studies have been conducted on adult patients with IBD in order to define the role of MRE in assessing sacroiliitis [18, 19], and the data available on pediatric patients have been obtained by MRI [20, 21].

Materials and methods

Patients

This is a retrospective study based on the review of clinical and imaging data of pediatric patients who underwent MRE between March 2010 and December 2018 for a suspicion of IBD or for disease follow-up at Meyer Children’s University Hospital of Florence, Italy.
Some patients underwent multiple examinations.
First, the feasibility of sacroiliac joints study on MRE examinations was evaluated, since a tailored sequence for this analysis was not normally included in standard MRE protocol.
The inclusion criteria were: (i) presence of T2 SPAIR or STIR sequences on coronal or axial plane; (ii) presence of DWI or DWIBS on coronal or axial plane; (iii) presence of T1W post gadolinium or dynamic contrast enhancement sequences; (iv) good diagnostic quality of these sequences.

Magnetic resonance Enterography protocol

MRE examinations were performed on 1.5 T (Achieva; Philips Medical System, Best, The Netherlands) or 3 T (Achieva, Philips Medical System) MRI scanners with a phased-array body coil, as previously described [17]. Patients were asked to follow a 4 days’ residue- free diet and a 6-h fast. Before the examination they were given a hyperosmotic oral aqueous solution mixed with dilute sorbitol at 70% (ACEF Spa, Piacenza, Italy) to be taken over a period of 40 to 45 min: the first 50 mL of sorbitol in 200 mL of water in 15 to 20 min and other 50 mL of sorbitol in 300 mL of water in 20 to 25 min. During the MRE patients were in the prone position and if not contraindicated a body weight-based dose of scopolamine (Buscopan; Boehringer Ingelheim, Ingelheim, Germany) was administered intravenously before the contrast agent to obtain bowel relaxation and peristalsis reduction. Gadoteratemeglumine (Dotarem, Guerbet, Villepinte, France, 0.5 mmol/mL) was used for all patients at the recommended dose of 0.2 mL/kg, followed by a saline flush. Standard MRE protocol is shown in Table 1.
Table 1
MRI protocol used at our institution for patients with Inflammatory Bowel Disease
Parameters
TR, ms
TE, ms
TI, ms
Matrix
B values
Slice Thickness,mm
cor dyn BTFE
4.7
2.4
228 × 224
10
ax BTFE F-B
3.5
1.7
192 × 159
3
cor BTFE F-B
3.8
1.9
288 × 188
3
cor T2 SPAIR
1060.5
70
244 × 188
3
ax DWI
2270.7
68.4
96 × 96
0–500-1000
4
ax DWIBS
9450.8
54.3
220
104 × 98
6
ax T2
856.9
70
208 × 158
3
cor T1 TFE SPIR
10
2.3
200 × 228
10
ax dyn THRIVE
3.1
1.5
172 × 172
3.6
cor T1 TFE SPIR mdc
10
2.3
228X168
5

Image analysis

Two blinded observers with experience in pediatric and skeletal imaging (AP, MDM) independently evaluated the images. Before reading the MRE, a consensus about the definition of inflammatory lesions in SI joints was reached. MRI signs of sacroiliitis in adults are described by the ASAS criteria [22], but at the moment, no such definition of a positive MRI for sacroiliitis exists in children with juvenile spondyloarthritis [23]. For this reason, and for the retrospective nature of this study, where targeted sequences for SI joints analysis on MRE lacked, we decided to evaluate the presence of bone marrow edema (using T2W sequences with fat suppression, SPAIR), as a defining sign of sacroiliitis. In addition, the presence of diffusion restriction in Diffusion Weighted Imaging (DWI) or Diffusion Weighted Imaging with Background Suppression (DWIBS), and dynamic contrast enhancement were evaluated. Each SI joint was divided into 4 quadrants: upper iliac, lower iliac, upper sacral, and lower sacral (Fig. 1). Cases upon which there was a disagreement were reevaluated together by the two reviewing radiologists and a third radiologist (MB) with similar experience.
Demographics, IBD features, clinical, radiological and laboratory data were recorded in a dedicated Excel database. No ethics committee approval was deemed necessary, since by local regulations anonimyzed data were used.

Results

We reviewed 128 MRE performed during the study period at our Radiological Unit.
Forty-six examinations did not meet inclusion criteria and were excluded since they did not have DWI sequences, which was initially optional in the MRE protocol, or sacroiliac joints were not included or only partially included in the examinations. Additionally, 23 examinations were excluded due to the poor diagnostic quality of the images needed for the sacroiliac joints analysis.
Thirty-four patients were therefore enrolled (24 males and 10 females, mean age at scanning 14.3 years, median 15.3 years) for a total of 59 examinations performed at the time of their first diagnosis or at symptoms exacerbations.
Two out of 34 patients were affected by UC, 32 by CD. Mean disease duration was 2.9 years, median 2.1 years. Clinical evaluation of the joints resulted negative in all patients and none complained of articular symptoms including back pain. At the time of MRE, 25 patients were under treatment: 14 were receiving immunosuppressants (methotrexate, azathioprine, 6-MP, thalidomide) or amynosalicilate (mesalazine), 6 were receiving biologic (anti-TNF) therapy, 3 were taking a combination of immunosuppressants and biologics, and 2 immunosuppressants associated with corticosteroids.
For all 59 MRE inter-reader agreement was good (Cohen’s kappa > 0.815). All cases of doubtful inflammatory sacroiliitis and discrepancy (n = 8) were resolved after discussion between the two reviewing radiologists and a third radiologist.
In 6 MRE scans (of 5 IBD patients), a monolateral slight degree of sacroiliitis was radiologically identified (Fig. 2). Five out of 6 MRE examination had positive findings in all sequences evaluated (T2 W, DWI/DWIBS and dynamic contrast enhancement), while 1 out of 6 had positive findings on T2 W, DWI/DWIBS without contrast enhancement. The characteristic of patients with sacroiliitis compared with patients without sacroiliitis on MRE are reported in Table 2. No significant differences between the two groups were seen.
Table 2
Characteristics of patients with sacroiliitis (YES) vs. without sacroiliitis (NO) at MRE
 
NO
YES
N = 29
N = 5
Characteristics
N
%
N
%
IBD
 UC
1
3.5
1
20
 CD
28
96.5
4
80
Gender
 Male
19
65.5
5
100
 Female
10
34.5
0
0
Mean age at scanning (years)
14.4
N/A
13.7
N/A
Mean disease duration (years)
3.6
N/A
2.9
N/A
ESR > 15 mm/h
16
55.2
4
80
CRP > 0.5 mg/dl
14
48.2
1
20
Therapy at the time of MRE
 IS
11
38
3
60
 IS and biologicals
3
10.3
0
0
 IS and CS
2
6.9
0
0
 Biologicals
4
13.8
2
40
 No therapy
9
31
0
0
CD Crohn’s disease, UC ulcerative colitis, CRP C-reactive protein, CS corticosteroids, IBD inflammatory bowel disease, IS immunosuppressants (methotrexate, azathioprine, 6-MP thalidomide) or amynosalicylate (mesalazine), MRE magnetic resonance enterography, N/A not applicable
Four out of the five patients had no clinical, laboratory or radiological signs of intestinal inflammation at the time of MRE. One patient presented with signs of intestinal and sacroiliac inflammation at his first MRE. The MRE control performed after 18 months of pharmacological treatment (Infliximab) showed the disappearance of intestinal signs of inflammation, while MR signs of sacroiliitis were still present (Fig. 3).

Discussion

To the best of our knowledge there are no data regarding the prevalence of sacroiliitis detected on MRE in pediatric IBD patients. Most studies report the prevalence of articular involvement (both peripheral and axial) in children with IBD being between 7 and 25% [2, 3, 12], more frequently in CD than UC patients [12, 24]. However, data have been obtained with standard MRI and not with MRE. Moreover, this wide range is probably due to the absence of clinical symptoms of many sacroiliitis diagnosed with MRI [12, 20]. If not diagnosed, sacroiliac inflammation is likely to progress with poor therapeutic prognosis [2528] .
In our series, SI inflammation was present in about 15% of cases; of note, none of them had SI inflammatory symptoms, partially in agreement with the literature data [12, 20] which reported that up to 50% of IBD patients may be asymptomatic and only 24% of children with enthesitis-related arthritis complain of pain, stiffness or limitation of motion of the lumbosacral spine at presentation [5].
We think that it may be useful to evaluate SI inflammation in patients undergoing MRE for IBD, in order to reduce underdiagnoses in asymptomatic subjects. We also noted that all patients with SI joint edema had also a restricted diffusion in DWIBS or DWI, and almost everyone had contrast uptake, so the use of gadolinium could be avoided in pediatric patients as it does not contribute to the diagnosis, in agreement with previous studies on adult patients [22, 29]. This is a great benefit considering the necessity for patients to undergo several diagnostic procedure during the course of the disease.
We also suggest that in case of SI radiological abnormalities, even if with only mild edema, rheumatology team should be involved. This would implicate thorough physical examination, and a clinical follow-up. If needed, repeated scans might be needed and in case of clinical symptoms patient management might also be changed. This is an exploratory study and the number of patients included is small.
Limitations of our study are its retrospective nature and the fact that the orientation of the acquisition planes is not completely suitable for the SI joints analysis. In agreement with the recent literature [21], we suggest that it might be useful to add a sequence targeted to SI evaluation during a MRE. However, our study is the first of its kind and we think that our results could help to improve the management of extraintestinal manifestations of IBD and the therapeutic approach when both spondyloarthropathy and IBD are associated.
In conclusion, this pilot study demonstrates that MRE may be a good tool to detect early signs of SI inflammation, even in asymptomatic patients, but for a better evaluation of SI joints dedicated sequences may be necessary. Moreover, with the addition of such sequences not only the diagnostic accuracy could be improved but IBD patients could be spared the necessity of standard MRI even when symptomatic, since MRE are routinely used during follow-up.

Acknowledgments

Not applicable.
No ethics committee approval was deemed necessary, since by local regulations anonimyzed data were used.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol. 2006;12(20):3204–12.CrossRef Diefenbach KA, Breuer CK. Pediatric inflammatory bowel disease. World J Gastroenterol. 2006;12(20):3204–12.CrossRef
2.
Zurück zum Zitat Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin N Am. 2002;31(1):307–27.CrossRef Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin N Am. 2002;31(1):307–27.CrossRef
3.
Zurück zum Zitat Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999;44(1):1–13.CrossRef Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci. 1999;44(1):1–13.CrossRef
4.
Zurück zum Zitat Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):63–8.CrossRef Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):63–8.CrossRef
5.
Zurück zum Zitat Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology. /th ed. Philadelphia: Elvesier; 2016. p. 268–73. Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology. /th ed. Philadelphia: Elvesier; 2016. p. 268–73.
6.
Zurück zum Zitat de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. 2000;27(12):2860–5.PubMed de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. 2000;27(12):2860–5.PubMed
7.
Zurück zum Zitat Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009;15(20):2449–55.CrossRef Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009;15(20):2449–55.CrossRef
8.
Zurück zum Zitat Dekker-Saeys BJ, Meuwissen SG, Van Den Berg-Loonen EM, De Haas WH, Agenant D, Tytgat GN. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis. 1978;37(1):33–5.CrossRef Dekker-Saeys BJ, Meuwissen SG, Van Den Berg-Loonen EM, De Haas WH, Agenant D, Tytgat GN. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis. 1978;37(1):33–5.CrossRef
9.
Zurück zum Zitat Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum. 2001;44(12):2728–36.CrossRef Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum. 2001;44(12):2728–36.CrossRef
10.
Zurück zum Zitat Van der Linden SJ, van der Heijde D. Spondyloarthropathies: ankylosing spondylitis In: Ruddy S, Harris ED, Sledge CB. Kelley’s textbook of rheumatology. 6th ed. Philadelphia: WB Saunders; 2001. p. 1039–53. Van der Linden SJ, van der Heijde D. Spondyloarthropathies: ankylosing spondylitis In: Ruddy S, Harris ED, Sledge CB. Kelley’s textbook of rheumatology. 6th ed. Philadelphia: WB Saunders; 2001. p. 1039–53.
11.
Zurück zum Zitat Brakenhoff LK, van der Heijde DM, Hommes DW, Huizinga TW, Fidder HH. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis. 2010;4(3):257–68.CrossRef Brakenhoff LK, van der Heijde DM, Hommes DW, Huizinga TW, Fidder HH. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis. 2010;4(3):257–68.CrossRef
12.
Zurück zum Zitat Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol. 2014;20(1):45–52.CrossRef Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol. 2014;20(1):45–52.CrossRef
14.
Zurück zum Zitat Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000–8.CrossRef Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000–8.CrossRef
15.
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.CrossRef Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.CrossRef
16.
Zurück zum Zitat Bennett AN, McGonagle D, O’Connor P, Hensor EMA, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 2008;58(11):3413–8.CrossRef Bennett AN, McGonagle D, O’Connor P, Hensor EMA, Sivera F, Coates LC, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum. 2008;58(11):3413–8.CrossRef
17.
Zurück zum Zitat Scionti A, Di Maurizio M, Basile M, Bernardini A, Miccoli M, Lionetti P, et al. Quantitative analysis of apparent diffusion coefficient for disease assessment in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019;68(3):353–9.CrossRef Scionti A, Di Maurizio M, Basile M, Bernardini A, Miccoli M, Lionetti P, et al. Quantitative analysis of apparent diffusion coefficient for disease assessment in paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019;68(3):353–9.CrossRef
18.
Zurück zum Zitat Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther. 2014;39(9):957–62.CrossRef Leclerc-Jacob S, Lux G, Rat AC, Laurent V, Blum A, Chary-Valckenaere I, et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther. 2014;39(9):957–62.CrossRef
19.
Zurück zum Zitat Gotler J, Amitai MM, Lidar M, Aharoni D, Flusser G, Eshed I. Utilizing MR enterography for detection of sacroiliitis in patients with inflammatory bowel disease. J Magn Reson Imaging. 2015;42(1):121–7.CrossRef Gotler J, Amitai MM, Lidar M, Aharoni D, Flusser G, Eshed I. Utilizing MR enterography for detection of sacroiliitis in patients with inflammatory bowel disease. J Magn Reson Imaging. 2015;42(1):121–7.CrossRef
20.
Zurück zum Zitat Herregods N, Dehoorne J, Van den Bosch F, Jaremko JL, Van Vlaenderen J, Joos R, et al. ASAS definition for sacroiliitis on MRI in SpA: applicable to children? Pediatr Rheumatol Online J. 2017;15(1):24.CrossRef Herregods N, Dehoorne J, Van den Bosch F, Jaremko JL, Van Vlaenderen J, Joos R, et al. ASAS definition for sacroiliitis on MRI in SpA: applicable to children? Pediatr Rheumatol Online J. 2017;15(1):24.CrossRef
21.
Zurück zum Zitat Wagle S, Gu JT, Courtier JL, Phelps AS, Lin C, MacKenzie JD. Value of dedicated small-field-of-view sacroiliac versus large-field-of-view pelvic magnetic resonance imaging for evaluating pediatric sacroiliitis. Pediatr Radiol. 2019;49(7):933–40.CrossRef Wagle S, Gu JT, Courtier JL, Phelps AS, Lin C, MacKenzie JD. Value of dedicated small-field-of-view sacroiliac versus large-field-of-view pelvic magnetic resonance imaging for evaluating pediatric sacroiliitis. Pediatr Radiol. 2019;49(7):933–40.CrossRef
22.
Zurück zum Zitat Lambert RGW, Bakker PAC, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. 2016;75(11):1958–63.CrossRef Lambert RGW, Bakker PAC, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, et al. Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group. Ann Rheum Dis. 2016;75(11):1958–63.CrossRef
23.
Zurück zum Zitat Herregods N, Dehoorne J, Jaremko J, Joos R, Baraliakos X, Verstraete K, et al. Diagnostic value of MRI of the sacroiliac joints in juvenile spondyloarthritis. J Belg Soc Radiol. 2016;100(1):95.CrossRef Herregods N, Dehoorne J, Jaremko J, Joos R, Baraliakos X, Verstraete K, et al. Diagnostic value of MRI of the sacroiliac joints in juvenile spondyloarthritis. J Belg Soc Radiol. 2016;100(1):95.CrossRef
24.
Zurück zum Zitat Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9(10):2300–7.CrossRef Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9(10):2300–7.CrossRef
25.
Zurück zum Zitat Colbert RA. Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6(8):477–85.CrossRef Colbert RA. Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6(8):477–85.CrossRef
26.
Zurück zum Zitat Weiss PF, Xiao R, Biko DM, Chauvin NA. Assessment of sacroiliitis at diagnosis of juvenile spondyloarthritis by radiography, magnetic resonance imaging, and clinical examination. Arthritis Care Res. 2016;68(2):187–94.CrossRef Weiss PF, Xiao R, Biko DM, Chauvin NA. Assessment of sacroiliitis at diagnosis of juvenile spondyloarthritis by radiography, magnetic resonance imaging, and clinical examination. Arthritis Care Res. 2016;68(2):187–94.CrossRef
27.
Zurück zum Zitat Tse SML, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):269–79.CrossRef Tse SML, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):269–79.CrossRef
28.
Zurück zum Zitat Bray JP, Vendhan K, Ambrose N, Atkinson D, Punwani S, Fisher C, et al. Diffusion-weighted imaging is a sensitive biomarker of response to biologic therapy in enthesitis-related arthritis. Rheumatology. 2017;56(3):399–407. Bray JP, Vendhan K, Ambrose N, Atkinson D, Punwani S, Fisher C, et al. Diffusion-weighted imaging is a sensitive biomarker of response to biologic therapy in enthesitis-related arthritis. Rheumatology. 2017;56(3):399–407.
29.
Zurück zum Zitat Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, et al. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum. 2005;53(4):502–9.CrossRef Maksymowych WP, Inman RD, Salonen D, Dhillon SS, Williams M, Stone M, et al. Spondyloarthritis research consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum. 2005;53(4):502–9.CrossRef
Metadaten
Titel
Usefulness of magnetic resonance enterography in detecting signs of sacroiliitis in young patients with inflammatory bowel disease
verfasst von
Teresa Giani
Azzurra Bernardini
Massimo Basile
Marco Di Maurizo
Anna Perrone
Sara Renzo
Viola Filistrucchi
Rolando Cimaz
Paolo Lionetti
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
Pediatric Rheumatology / Ausgabe 1/2020
Elektronische ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00433-w

Weitere Artikel der Ausgabe 1/2020

Pediatric Rheumatology 1/2020 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.